HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry-Backed Cosmetics Bill Will “Not Be Easy To Pass” – Rep. Lance

This article was originally published in The Rose Sheet

Executive Summary

At a May 7 press conference held at L’Oreal USA’s Research and Innovation Center, Rep. Leonard Lance, R-N.J., admitted having “a lot of work to do” to convince colleagues that the Safe Cosmetics Alliance-backed Cosmetic Safety Amendments Act “is the way forward.”

You may also be interested in...



Rep. Lance, Council Work To Generate Support For Cosmetics Bill

New Jersey Rep. Leonard Lance will discuss his cosmetics bill, the Cosmetic Safety Amendments Act, with L’Oreal employees at a news conference on May 7. The bill is also backed by the Personal Care Products Council, which is working to gain legislative support from both parties.

In Brief

At its annual FDA Cosmetic Regulatory Workshop, ICMAD encourages members to support new cosmetics safety legislation launched Apr. 18 by Rep. Leonard Lance, R-N.J. Additionally, RIFM adds a new president, Dr. David K. Wilcox, and FDA names Walter Harris COO.

FDA Proposes $19 Mil. In Cosmetics User Fees To Support Enhanced Oversight

With almost $19 million in user fees proposed for cosmetics manufacturers in FDA’s budget request, the agency intends to overhaul regulation of the personal-care industry.

Topics

Related Companies

UsernamePublicRestriction

Register

RS018099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel